Erlotinib treatment for persistent spontaneous pneumothorax in non-small cell lung cancer: a case report

Chin Med J (Engl). 2010 Dec;123(23):3501-3.

Authors

Sheng-Xiang Ren¹, Song-Wen Zhou, Ling Zhang, Cai-Cun Zhou

Affiliation

¹ Department of Medical Oncology, Tongji University Affiliated Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Shanghai 200433, China.

PMID: 22166539

No abstract available

Publication types

Case Reports
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Non-Small-Cell Lung / complications
Carcinoma, Non-Small-Cell Lung / drug therapy*
Erlotinib Hydrochloride
Humans
Lung Neoplasms / complications
Lung Neoplasms / drug therapy*
Male
Middle Aged
Pneumothorax / etiology
Pneumothorax / prevention & control*
Protein Kinase Inhibitors / therapeutic use*
Quinazolines / therapeutic use*

Substances

Protein Kinase Inhibitors
Quinazolines
Erlotinib Hydrochloride